Evotec to attend upcoming investor conferences

 

Hamburg, Germany, 03 September 2018:
Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today that its management will be presenting and attending the following conferences:  

 

Goldman Sachs 8th Annual Biotech Symposium, London, UK

Date: Friday, 07 September 2018

Venue: London, UK

Attendee: Enno Spillner, Chief Financial Officer

 

J.P. Morgan Cazenove Pan-European Small/Mid Cap Conference, London, UK

Date: Wednesday, 12 September 2018

Venue: London, UK

Attendee: Enno Spillner, Chief Financial Officer

 

Morgan Stanley 16th Annual Global Healthcare Conference, New York, USA

Date: Thursday, 13 September, to Friday, 14 September 2018,

Presentation: 14 September 2018, 01.00 pm EDT (06.00 pm BST, 07.00 pm CEST)

Venue: New York, USA

Attendee: Dr Werner Lanthaler, Chief Executive Officer

 

Baader Investment Conference, Munich, Germany

Date: Monday, 24 September 2018, 02.00 pm CEST (01.00 pm BST, 08.00 am EDT)

Venue: Munich, Germany

Attendee: Enno Spillner, Chief Financial Officer

 

Berenberg and Goldman Sachs Seventh German Corporate Conference, Munich, Germany

Date: Wednesday, 26 September 2018, 02.30 pm CEST (01.30 pm BST, 08.30 am EDT)

Venue: Munich, Germany

Attendee: Dr Werner Lanthaler, Chief Executive Officer

 

Cantor Global Healthcare Conference 2018, New York, USA

Date: Monday, 01 October, to Tuesday, 02 October 2018,

Presentation: 02 October 2018, 08.35 am EDT (01.35 pm BST, 02.35 pm CEST)

Venue: New York, USA

Attendee: Enno Spillner, Chief Financial Officer

 

FORWARD LOOKING STATEMENTS 

Information set forth in this press release contains forward-looking statements, which involve a number of risks and uncertainties. The forward-looking statements contained herein represent the judgement of Evotec as of the date of this press release. Such forward-looking statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond our control, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based.